Sensus Healthcare, Inc. (SRTS) Tops Q2 EPS by 8c

Sensus Healthcare, Inc. (NASDAQ: SRTS) reported Q2 EPS of $0.21, $0.08 better than the analyst estimate of $0.13. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $9.56 million.

For earnings history and earnings-related data on Sensus Healthcare, Inc. (SRTS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c